1
2
13C{ H} (100.6 MHz, CDCl3) d: 147.3 (d, JPC = 20.7, C N),
139.6 (br d, 2JPC = 18, o-C6H5), 136.4 (br d, 2JPC = 18, o-C6H5),
131.9 (s, p-C6H5), 131.5 (d, 1JPC = 51, i-C6H5), 127.2 (br, m-C6H5),
50.4 (d, 4JPC = 5.5, =NCH), 47.5 (s, NCH), 45.9 (s, NCH), 24.2 (s,
=
C
1,1ꢀH C6H11 + OCH2CH2N), 3.19 (4H, m, OCH2CH2N), 1.83–
1
0.90 (20H, m, C6H11); 13C{ H} (125.7 MHz, C6D6) d: 153.6 (d,
2
=
JPC = 20.5, C N), 140.7 (br s, i-C6H5), 135.3 (br s, o-C6H5), 131.8
(br s, o-C6H5), 128.4 (br s, m- + p-C6H5), 67.0 (s, OCH2CH2N),
2
60.2 (d, JPC = 5.5, C1H-C6H11), 57.0 (s, C1H-C6H11), 50.1 (s,
CH3), 22.0 (s, CH3), 21.2 (s, CH3); 31P{ H} (101.3 MHz, CDCl3)
1
OCH2CH2N), 36.0 (br s, C2/2ꢀH2–C6H11), 33.9 (br s, C2/2H2–
d: + 49.9; MS (FAB+): 412 (MH)+.
ꢀ
C6H11), 27.5 (br s, C3/3H2–C6H11), 26.9 (br s, C4/4 H2–C6H11),
1
26.4 (br s, C4/4ꢀH2–C6H11), 25.7 (br s, C3/3ꢀH2–C6H11); 31P{ H}
N,Nꢀ-Dicyclohexyl-N-diphenylphosphino-piperidine-1-
carboxamidine 2
(125.7 MHz, C6D6) d: +49.8 (s); MS (FAB+): 478 (MH)+.
To a stirred, cooled (−78 ◦C) solution of piperidine (0.42 mL,
4.85 × 10−3 mol) in diethyl ether (15 mL) was added dropwise
BunLi (2.55 M, pentane, 1.9 mL, 4.85 × 10−3 mol), and the vessel
left to warm to RT over 2 h. After re-cooling (−78 ◦C), an ethereal
(25 mL), cooled solution of N,N ꢀ-dicyclohexylcarbodiimide (1.0 g,
4.85 × 10−3 mol) was added dropwise via cannula. The mixture was
allowed to warm to RT, then stirred for 2 h. Volatile components
were removed in vacuo. The resulting solid was dissolved in Et2O
(20 mL), cooled at −78 ◦C and Ph2PCl (0.87 mL, 4.85 × 10−3 mol)
was added dropwise, to give an opaque white solution. The mixture
was allowed to warm slowly to RT, then stirred for 18 h. The
solvents were removed under vacuum, hexane added and the
mixture filtered. Concentration and recrystallisation from hexane
afforded 2 as a white solid (1.70 g, 74%). Anal. Calc. for C30H42N3P
requires: C, 75.75; H, 8.90; N, 8.83. Found: C, 75.81; H, 8.99; N,
8.87. 1H (499.9 MHz, CDCl3) d: 7.50 (4H, br s, o-C6H5), 7.35 (6H,
m, m- + p-C6H5), 3.49 (1H, m, C1H C6H11), 3.40 (1H, m, C1ꢀH
C6H11), 3.03 (4H, m, C1H2 pip); 1.87–0.80 (26H, 4 overlapping m,
N,Nꢀ-Dicyclohexyl-N-diphenylphosphino-acetamidine 4
◦
To a stirred, cooled (−78 C) solution of N,N ꢀ-dicyclohexyl-
carbodiimide (1.0 g, 4.85 × 10−3 mol) in diethyl ether (25 mL)
was added dropwise MeLi (1.6 M, hexane, 3.0 mL, 4.85 ×
10−3 mol), and th◦ e vessel left to warm to RT over 1 h. After
re-cooling (−78 C), Ph2PCl (0.87 mL, 4.85 × 10−3 mol) was
added dropwise. The mixture was allowed to warm to RT, then
stirred for 18 h. The solvents were removed under vacuum, pentane
added and the solution filtered. Prolonged standing in pentane
gave rise to colourless crystals of 4 suitable for an X-ray structure
determination (1.65 g, 84%). Anal. Calc. for C26H35N2P requires:
C, 76.81; H, 8.68; N, 6.89. Found: C, 76.71; H, 8.64; N, 6.80.
1H (499.8 MHz, CDCl3) d: 7.53–7.27 (10H, m, C6H5), 4.02 (m,
1H, C1/1H-C6H11), 3.03 (1H, m, C1/1H-C6H11), 1.58 (3H, s, CH3),
1
2.02–1.21 (20H, m, CH2–C6H11); 13C{ H} (125.7 MHz, CDCl3) d:
1
155.7 (d, 2JPC 1, C N), 139.1 (d, JPC = 17, i-C6H5), 131.4 (d, JPC
=
=
20.23, o- or m-C6H5), 128.2 (d, JPC = 5, o- or m-C6H5), 128.1 (s,
p-C6H5), 58.5 (d, 2JPC = 17.5, C1ꢀH-C6H11), 57.4 (s, C1H-C6H11),
34.6 (s, C2H2–C6H11), 33.3 (d, 3JPC = 11.5, C2ꢀH2–C6H11), 26.8 (s,
1
2
C6H11 + pip); 13C{ H} (125.6 MHz, CDCl3) d: 154.8 (d, JPC
=
1
2
=
21, C N), 139.9 (d, JPC = 102, i-C6H5), 135.0 (d, JPC = 20, o-
C6H5), 131.3 (d, 2JPC = 16, o-C6H5), 129.8 (s, p-C6H5), 128.3 (br s,
C
3/3ꢀH2–C6H11), 26.3 (s, C4/4ꢀH2–C6H11), 26.1 (s, C4/4ꢀH2–C6H11),
2
3
1
m-C6H5), 59.8 (d, JPC = 5, C1H-C6H11), 56.6 (s, C1H-C6H11),
24.8 (s, C3/3ꢀH2–C6H11), 17.0 (d, JPC = 7 Hz, CH3); 31P{ H}
(161.90 MHz, CDCl3) d: +37.0; MS (EI): 406 (M), 329 (M-Ph),
221 (M-PPh2).
49.5 (s, C1H2 pip), 35.3 (br s, C2/2ꢀH2 C6H11), 33.2 (br s, C2/2ꢀH2–
C6H11), 26.7 (br s, C3/3ꢀH2–C6H11), 26.1 (s, C4/4ꢀH2–C6H11), 26.0 (s,
C
4/4ꢀH2–C6H11), 25.7 (s, C2H2–C5H10N), 25.2 (br s, C3/3ꢀH2–C6H11),
24.9 (s, C3H2–C5H10N); 31P{ H} (161.90 MHz, CDCl3) d: +50.2;
1
N,Nꢀ-Dicyclohexyl-N-diphenylphosphino-benzamidine 5
MS (ES+): 292.4 (M-PPh2)+.
◦
To a stirred, cooled (−78 C) solution of N,N ꢀ-dicyclohexyl-
carbodiimide (1.0 g, 4.85 × 10−3 mol) in diethyl ether (25 mL) was
added dropwise PhLi (2.0 M, Bu2O, 2.4 mL, 4.85 × 10−3 mol),
and the vessel left to warm to RT over 2 h. After re-cooling
(−78 ◦C), an ethereal, cooled solution (10 mL) of Ph2PCl (0.87 mL,
4.85 × 10−3 mol) was added dropwise via cannula. The mixture
was allowed to warm to RT, then stirred for 18 h. The volatile
components were removed under vacuum, hexane added and
the mixture filtered. Removal of the solvent in vacuo afforded
5 as a white solid (1.74 g, 83%) that was used without further
purification. Anal. Calc. for C31H37N2P requires: C, 79.45; H, 7.96;
N, 5.98. Found: C, 79.51; H, 8.00; N, 6.01. 1H (499.8 MHz, CDCl3)
N,Nꢀ-Dicyclohexyl-N-diphenylphosphino-4-
morpholinecarboxamidine 3
◦
To a stirred, cooled (−78 C) solution of N,N ꢀ-dicyclohexyl-4-
morpholinecarboxamide (9.43 g, 3.21 × 10−2 mol) in diethyl ether
(200 mL) was added dropwise BunLi (2.0 M, pentane, 16.1 mL,
3.21 × 10−2 mol), and the vessel left to warm to RT over 1 h, to give
an opaque white solution. After re-cooling (−78 ◦C), an ethereal
solution (80 mL) of Ph2PCl (5.8 mL, 3.21 × 10−2 mol) was added
dropwise via cannula. The mixture was allowed to stir at −78 ◦C for
1 h before being left to warm to RT, then stirred for 18 h, resulting
in a colourless solution with a thick white precipitate. Removal
of solvent under reduced pressure left a yellow oil. Addition, and
subsequent removal, of CH2Cl2 (50 mL) gave a yellow oily solid.
Dissolution of the oil in toluene and filtration through a glass frit
to remove the white solid, gave an orange solution. Concentration
and crystallisation at −30 ◦C gave colourless crystals of 3 suitable
for an X-ray structure determination (11.34 g, 74%). Anal. Calc.
for C29H40N3OP: C, 72.93; H, 8.44; N, 8.80%. Found: C, 72.99; H,
3
d: 7.57 (4H, pseudo-t, JHH = 16.0, o-(P)C6H5), 7.60–7.10 (9H,
m, C6H5), 7.08 (2H, d,3JHH = 8.0, o-C6H5), 3.15 (1H, m, C1,1ꢀH-
C6H11), 2.54 (1H, m, C1,1ꢀH-C6H11), 2.27 (2H, m, C6H11), 1.66–0.80
1
(18H, m, C6H11); 13C{ H} (125.6 MHz, CDCl3) d: 157.2 (d, 2JPC
=
1
3
=
9, C N), 138.9 (d, JPC = 15, i-(P)C6H5), 136.4 (d, JPC = 2, i-
C6H5), 132.6 (d, 2JPC = 21.5, o-(P)C6H5), 128.4 and 128.1 (s, o- +
3
m-C6H5), 127.9 (s, p-C6H5), 127.8 (d, JPC = 6.5, m-(P)C6H5),
127.4 (d, 4JPC = 2, p-(P)C6H5), 59.9 (d, 2JPC = 10, C1ꢀH-C6H11),
1
3
8.48; N, 8.86%. H (499.9 MHz, C6D6) d: 7.59 (4H, br pseudo-t,
58.8 (s, C1H-C6H11), 33.3 (d, JPC = 8.2, C2ꢀH2–C6H11), 34.7 (s,
3JHH = 7.0, o-C6H5), 7.09 (6H, m, m- + p-C6H5), 3.80–3.49 (6H, m,
C2H2–C6H11), 26.8 (s, CH2), 26.1 (s, CH2), 25.8 (s, CH2), 24.6 (s,
1050 | Dalton Trans., 2008, 1043–1054
This journal is
The Royal Society of Chemistry 2008
©